Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 5, 2004 - Issue 8
Submit an article Journal homepage
50
Views
1
CrossRef citations to date
0
Altmetric
Miscellaneous

New drugs for the prevention and treatment of migraine: topiramate and BIBN 4096 BS

Sheila A Doggrell Doggrell Biomedical Communications, 47 Caronia Crescent, Lynfield, Auckland, New Zealand. [email protected]
Pages 1837-1840 | Published online: 25 Feb 2005

Bibliography

  • OLSEN J, DIENER HC, HUSSTEDT IW et al.: Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl. Med. (2004) 350:1104–1110.
  • BRANDES JL, SAPER JR, DIAMOND M et al.: Topiramate for migraine prevention: a randomized controlled trial. JAMA (2004) 291: 965–973.
  • GOADSBY PJ, LIPTON RB, FERRARI MD: Migraine — current understanding and treatment. N Engl. Med. (2002) 346:257–270.
  • STOREY JR, CALDER CS, HART DE, POTTER DL: Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache (2001) 41:968–975.
  • PASCUAL J, SANCHEZ DEL RIO M, MATE OS V et al.: Topiramate for patients with refractory migraine: an observational, multicenter study in Spain. Neurologic (2003) 18:364–367.
  • MARTINEZ HR, LONDONO 0, CANTU-MARTINEZ, DEL CARMEN TARIN L, CASTILLO CD: Topiramate as an adjunctive treatment in migraine prophylaxis. Headache (2003) 43:1080–1084.
  • SILBERSTEIN SD, NETO W, SCHMITT J, JACOBS D: Topiramate in migraine prevention: results of a large controlled trial. Arch. Neurol (2004) 61:490–495.
  • FREITAG FG, COLLINS SD, CARLSON BA et al.: A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology (2002) 58:1652–1659.
  • TRONVIK E, STROVNER LJ, HELDE G, SAND T, BOVIM G: Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA (2003) 289:65–69.
  • DOGGRELL SA: Migraine and beyond: cardiovascular therapeutic potential for CGRP modulators. Expert Opin. Investig. Drugs (2001) 10:1131–1138.
  • DOODS H, HALLERMAYER C, WU D et al.: Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br. Pharmacol (2000) 129:420–423.
  • MORENO MJ, ABOUNADER R, HEBERT E, DOODS H, HAMEL E: Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment. Neuropharmacology (2002) 42:568–576.
  • THE SUBCUTANEOUS SUMATRIPTAN INTERNATIONAL STUDY GROUP: Treatment of migraine attacks with sumitriptan. N Engl. I Med. (1991) 325:316–321.
  • FERRARI MD, ROON KI, LIPTON RB, GOADSBY PJ: Oral triptans (serotonin 5-HTIB/ID agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (2001) 358: 1668-1675.
  • TEPPER SJ, MILLSON D: Safety profileof the triptans. Expert Opin. Drug Sal (2003) 2:123–132.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.